Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
52,134,758
-
Share change
-
+2,870,713
-
Total reported value
-
$213,218,929
-
Put/Call ratio
-
313%
-
Price per share
-
$4.09
-
Number of holders
-
82
-
Value change
-
+$11,686,818
-
Number of buys
-
46
-
Number of sells
-
28
Institutional Holders of SYNTA PHARMACEUTICALS CORP - COM (SNTA) as of Q2 2014
As of 30 Jun 2014,
SYNTA PHARMACEUTICALS CORP - COM (SNTA) was held by
82 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
52,134,758 shares.
The largest 10 holders included
CAXTON CORP, FMR LLC, JENNISON ASSOCIATES LLC, BlackRock Fund Advisors, VANGUARD GROUP INC, D. E. Shaw & Co., Inc., GOLDMAN SACHS GROUP INC, State Street Corp, BlackRock Institutional Trust Company, N.A., and NORTHERN TRUST CORP.
This page lists
82
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.